Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic fatal lung disease without a cure and new drug strategies are urgently needed. Differences in behavior between diseased and healthy cells are well known and drug response can be different between cells isolated from IPF patients an...

Full description

Bibliographic Details
Main Authors: Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, Nina Hobi, Simone Ebener, Cedric Simillion, Andrea Stokes, Ronja Schliep, Lars Knudsen, Thomas K. Geiser, Manuela Funke-Chambour
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Respiratory Research
Subjects:
Idiopathic pulmonary fibrosis (IPF)
Anti-fibrotic drug
Azithromycin
Lysosomes
Apoptosis
Online Access:https://doi.org/10.1186/s12931-020-1275-8

Internet

https://doi.org/10.1186/s12931-020-1275-8

Similar Items